Technical Analysis for MYOK - MyoKardia, Inc.

Grade Last Price % Change Price Change
grade C 71.4 -1.87% -1.36
MYOK closed down 1.87 percent on Wednesday, January 22, 2020, on 83 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down
Historical MYOK trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
20 DMA Support Bullish -1.87%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.87%
Bollinger Band Squeeze Range Contraction -1.87%
BB Squeeze Started Range Contraction -1.87%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

MyoKardia, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for the treatment of serious and neglected rare cardiovascular diseases. Its lead product candidate is MYK-461, a small molecule that is in three Phase I clinical trials designed to reduce excessive cardiac muscle contractility leading to hypertrophic cardiomyopathy (HCM). The company also develops DCM-1, a product candidate that treats heritable dilated cardiomyopathy (DCM) by restoring normal contractility in the diseased DCM heart. In addition, it develops HCM-2, a product candidate to reduce cardiac muscle contractility to normal levels in HCM patients; and LUS-1, a product candidate, which is intended to counteract a muscle disruption that results in impaired relaxation of the heart. MyoKardia, Inc. has a strategic collaboration with Sanofi S.A. The company was founded in 2012 and is headquartered in South San Francisco, California.
Medical Specialties Anatomy Sports Medicine Cardiomyopathy Muscular System

Is MYOK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 78.28
52 Week Low 39.01
Average Volume 391,654
200-Day Moving Average 55.51
50-Day Moving Average 66.67
20-Day Moving Average 72.76
10-Day Moving Average 72.98
Average True Range 2.63
ADX 23.71
+DI 24.23
-DI 21.26
Chandelier Exit (Long, 3 ATRs ) 70.40
Chandelier Exit (Short, 3 ATRs ) 74.59
Upper Bollinger Band 76.56
Lower Bollinger Band 68.96
Percent B (%b) 0.32
BandWidth 10.45
MACD Line 1.74
MACD Signal Line 2.11
MACD Histogram -0.3744
Fundamentals Value
Market Cap 2.25 Billion
Num Shares 31.5 Million
EPS -0.65
Price-to-Earnings (P/E) Ratio -109.85
Price-to-Sales 26.88
Price-to-Book 9.37
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 75.51
Resistance 3 (R3) 75.81 74.73 74.83
Resistance 2 (R2) 74.73 73.69 74.59 74.60
Resistance 1 (R1) 73.07 73.04 72.53 72.77 74.37
Pivot Point 71.99 71.99 71.73 71.85 71.99
Support 1 (S1) 70.33 70.95 69.79 70.03 68.43
Support 2 (S2) 69.25 70.30 69.11 68.20
Support 3 (S3) 67.59 69.25 67.98
Support 4 (S4) 67.29